Compare · EW vs PKOH
EW vs PKOH
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Park-Ohio Holdings Corp. (PKOH): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while PKOH operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $49.83B, about 72.7x PKOH ($685.4M).
- Over the past year, EW is up 18.7% and PKOH is up 119.7% - PKOH leads by 101.0 points.
- PKOH has been more active in the news (9 items in the past 4 weeks vs 5 for EW).
- EW has more recent analyst coverage (25 ratings vs 4 for PKOH).
- Company
- Edwards Lifesciences Corporation
- Park-Ohio Holdings Corp.
- Price
- $86.30-2.02%
- $45.53-1.46%
- Market cap
- $49.83B
- $685.4M
- 1M return
- -2.26%
- -1.27%
- 1Y return
- +18.71%
- +119.66%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 5
- 9
- Recent ratings
- 25
- 4
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Park-Ohio Holdings Corp.
Park-Ohio Holdings Corp. provides supply chain management outsourcing services, capital equipment, and manufactured components in the United States, Europe, Asia, Mexico, Canada, and internationally. It operates through three segments: Supply Technologies, Assembly Components, and Engineered Products. The Supply Technologies segment offers Total Supply Management solution, including engineering and design support, part usage and cost analysis, supplier selection, quality assurance, bar coding, product packaging and tracking, just-in-time and point-of-use delivery, electronic billing, and ongoing technical support services, as well as provides spare parts and aftermarket products; and production components, such as valves, fuel hose assemblies, electro-mechanical hardware, labels, fittings, steering components, and other products. It also engineers and manufactures precision cold-formed and cold-extruded fasteners and other products, including locknuts, SPAC nuts, SPAC bolts, and wheel hardware. The Assembly Components segment manufactures aluminum products, direct fuel injection fuel rails and pipes, fuel filler pipes, and flexible multi-layer plastic and rubber assemblies; turbo charging and coolant hoses; and fluid handling systems. It also offers machining services, as well as value-added services, such as design engineering, machining, and part assembly. The Engineered Products segment designs and manufactures engineered products, including induction heating and melting systems, pipe threading systems, and forged and machined products primarily for ferrous and non-ferrous metals, silicon, coatings, forging, foundry, automotive, and construction equipment industries; engineers and installs mechanical forging presses; sells spare parts; provides field services; and offers aerospace and defense structural components, and rail products, such as railcar center plates and draft lugs. Park-Ohio Holdings Corp. was founded in 1907 and is headquartered in Cleveland, Ohio.
Latest EW
- SEC Form 4 filed by Edwards Lifesciences Corporation
- Barclays initiated coverage on Edwards Lifesciences with a new price target
- Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- Edwards Lifesciences to Host Investor Event in Conjunction With TCT
- Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 253 shares, decreasing direct ownership by 2% to 14,615 units (SEC Form 4) to satisfy withholding tax
- CVP, JAPAC Markowitz Wayne covered exercise/tax liability with 923 shares, decreasing direct ownership by 5% to 19,371 units (SEC Form 4) to satisfy tax liability
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $54,169 worth of shares (619 units at $87.51) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TMTT, Surgical & IHFM Chopra Daveen covered exercise/tax liability with 398 shares, decreasing direct ownership by 0.90% to 43,926 units (SEC Form 4) to satisfy tax liability
- Edwards Lifesciences Comments on TAVR National Coverage Decision
Latest PKOH
- Secretary & CLO Vilsack Robert D sold $148,069 worth of shares (3,190 units at $46.42) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 144,024 units (SEC Form 4)
- Secretary & CLO Vilsack Robert D sold $207,113 worth of shares (4,544 units at $45.58) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 147,214 units (SEC Form 4)
- Secretary & CLO Vilsack Robert D sold $90,339 worth of shares (1,941 units at $46.54) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 151,758 units (SEC Form 4)
- Secretary & CLO Vilsack Robert D sold $354,554 worth of shares (7,640 units at $46.41) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 153,699 units (SEC Form 4)
- Secretary & CLO Vilsack Robert D sold $306,087 worth of shares (6,497 units at $47.11) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 161,339 units (SEC Form 4)
- Secretary & CLO Vilsack Robert D sold $426,925 worth of shares (9,000 units at $47.44) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 167,836 units (SEC Form 4)
- Secretary & CLO Vilsack Robert D sold $337,402 worth of shares (7,188 units at $46.94) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 176,836 units (SEC Form 4)
- Director Wert James W sold $142,500 worth of shares (3,000 units at $47.50), decreasing direct ownership by 3% to 85,456 units (SEC Form 4)
- Director Wert James W sold $93,500 worth of shares (2,000 units at $46.75), decreasing direct ownership by 2% to 88,456 units (SEC Form 4)
- Director Wert James W sold $92,427 worth of shares (2,000 units at $46.21) and gifted 1,000 shares, decreasing direct ownership by 3% to 90,456 units (SEC Form 4)